doctor writing in a notebook with computer on a desk

QURE for Value-Based Care Transformation

Group Purchases

Request more information about our enterprise solutions and clinical resources from TRC Healthcare.

Empowering Consistent, Evidence-Based Care Decisions for Success in Value-Based Care

Improve Care. Reduce Costs. Keep Patients Healthy.

QURE Patient Simulations engage primary care providers and APPs across the country with interactive patient cases to transform real-world patient care.

  • Cases incorporate high-priority clinical decisions tied to key VBC metrics.
  • Participants receive real-time feedback on the most up-to-date evidence and guidelines.
  • Serial engagement with QURE cases and feedback over the year provides the opportunity to track changes in decision-making over time.
  • Group-wide performance insights and CME/MOC credits available upon completion.

QURE’s scientifically validated patient simulations empower practitioners to see gaps in their care decisions and get evidence-based guidance on the best decisions for their patients. Health systems get detailed insights on how clinical practice in their system compare to evidence-based guidelines. Participating practitioners receive real-time, personalized feedback on their improvement opportunities and see how they compare to their peers who treated the same patient.

Participants not only enhance their skills but also earn Continuing Medical Education (CME) and Maintenance of Certification (MoC) credits.

Stop working around your primary care providers. Instead, get them directly engaged in value-based care success with QURE’s patient simulation-based measurement and feedback platform. QURE cases are designed to help providers make evidence-based decisions that elevate performance on high-priority value-based care metrics, including hospitalization risk reduction, specifically referrals, and HCC documentation, ensuring consistent and superior care delivery.

QURE cases specifically address common valued-based care challenges in disease areas like:

  • Guideline Directed Medical Therapy for HFrEF and HFpEF
  • Symptomatic COPD Management
  • Diabetes Care for Older Adults
  • Care Transitions After COPD Hospitalization
  • Uncontrolled Diabetes Management
  • Advanced Heart Failure Management
  • Annual Wellness Visits
  • Polypharmacy Among Patients with Dementia

 

Check out our value-based care modules

QURE Patient Simulations and real-time feedback address elements of a typical patient encounter:

  • Diagnostic workup
  • Clinical documentation (incl. HCC v28)
  • Medication management
  • Specialist references
  • Support services
  • Preventive care
  • Social determinants of health assessment
  • Follow-up care plan

How QURE Changes Clinical Practice

Proven Outcomes

This real-world, quasi-controlled experiment compared ACO target improvements between 3 participating geographic regions and members within the ProHealth ACO against nonparticipating regions and members. Participants were PCPs and APPs across the state of Connecticut managing heart failure and diabetes. The paper highlights strong increases in care standardization, improvements in patient-level quality measures and estimated savings of nearly $5M from reductions in unneeded testing and specialist referrals. Population Health Management, 2019

QURE Healthcare engaged in a partnership that offered cardiologists within a Northeastern health plan access to an innovative, evidence-based cardiology enhancement project: standardizing care through QURE’s simulated patient cases.

Early Impact: analyzing the health plan’s claims data and comparing practice patterns of the QURE participants versus those that didn’t participate has shown:

  • 5% greater reduction in the rate of pharmacy spending for patients with cardiac disease from 2021 to 2023. Participating cardiologists showed a reduction of 7.9% vs 2.9% in non-participating cardiologists. This represents $3.2M less pharmacy spend.
  • 4x greater relative increase in referrals to cardiac rehabilitation. Non-participating cardiologists increased 47%, while participating cardiologists increased 200%. This represents 414 additional patients in cardiac rehab and an estimated savings of $373,000

We conducted a prospective, quasi-controlled cohort study of hospitalists in eight hospitals matched with comparator hospitalists in six nonparticipating hospitals across the AdventHealth system. Diseases studied were Sepsis and Heart Failure. This study had a quasi-experimental control group which allowed us to isolate the magnitude of the QURE impact, which delivered length of stay reductions and $2.4 M in annual savings above and beyond improvements seen from other system-level initiatives. Journal Hospital Medicine2019

We created a series of gamified acute-care COPD case simulations with real-time feedback over 16 weeks then performed a year-over-year analytic comparison of the cost, length of stay (LOS), and revisits over the six months prior to the introduction of the simulated patients, the four months while caring for the simulated patients, and the six months after. In total, 245 hospitalists from 15 facilities at Novant Health participated. Over the 16 weeks that the providers were actively engaged in the short cases, evidence-based quality scores in the cases increased by 12%. Importantly, these improvements translated in real-world data with a 19% reduction in COPD-related pharmacy costs, and an annualized impact of 233 fewer inpatient days for COPD patients and 371 fewer revisits, leading to inpatient savings of $1M. Healthcare, 2021

Fifty cardiologists from the Ochsner Health System cared for two simulated patients in each of six assessment rounds occurring 4 months apart. Simulated patients presented with heart failure (HF), coronary artery disease (CAD), supraventricular tachyarrhythmia (SVT) or valvular heart disease. Using Ochsner’s patient-level data, we performed real-world pre–post analyses of physician practice changes, patient outcomes and costs. The cardiologists showed increased care standardization across the group, reduced readmissions, and $4.3M in annual savings in the real-world data. Open Heart, 2019